High Tech Gruenderfonds II has received an investment from Bayer Pharma AG to back and support startups in the pharmeceutical sector.
Bayer joined the German Federal Ministry for Economic Affairs and Energy, the KfW bank group and a total of 20 private investors, in HTGF Fund II, which now totals €304m.
High-Tech Gruenderfonds II intends to provide promising startups in the life sciences and healthcare sectors (life science sectors biotechnology, diagnostics, healthcare, medical technology and pharmacy) with seed capital amounting to €500k, and necessary networks and contacts.
In 2013, 15 life science companies received such a seed financing.
FinSMEs
13/04/2014